Operational Highlights and Financial Results for the Period Ended December 31, 2021
Mesoblast Prepares for Resubmission of Biologics License Application Late-Stage Clinical Pipeline Late-Stage Clinical Pipeline NEW…
News
Jasper Therapeutics Announces JSP191 Phase 1b MDS/AML Late Breaking Data Presentation at the 2022 Transplantation & Cellular Therapy Tandem Meetings of ASTCT and CIBMTR
JSP191 is well tolerated with no treatment-related severe adverse events in 17 subjects with myelodysplastic…
Vericel Announces Appointment of Jonathan Siegal as Principal Accounting Officer
CAMBRIDGE, Mass., Feb. 24, 2022 (GLOBE NEWSWIRE) — Vericel Corporation (NASDAQ:VCEL), a leader in advanced…
Baudax Bio Announces Proposed Public Offering of Securities
MALVERN, Pa., Feb. 24, 2022 (GLOBE NEWSWIRE) — Baudax Bio, Inc. (the “Company” or “Baudax…
DBV Technologies to Report Full Year 2021 Financial Results and Business Updates on March 3, 2022
Montrouge, France, February 24, 2022 DBV Technologies to Report Full Year 2021 Financial Results and…
Cellectis to Hold Fourth Quarter 2021 Earnings Call on Friday March 4, 2022 at 8:00AM EST
NEW YORK, Feb. 24, 2022 (GLOBE NEWSWIRE) — Cellectis (Euronext Growth: ALCLS – Nasdaq: CLLS),…
Atreca to Report Fourth Quarter 2021 Results and Host Year-End Conference Call on March 3, 2022
SAN CARLOS, Calif., Feb. 24, 2022 (GLOBE NEWSWIRE) — Atreca, Inc. (Atreca) (NASDAQ: BCEL), a…
Generation Bio Outlines 2022 Strategic Priorities and Reports Fourth Quarter and Full Year 2021 Financial Results
Well-capitalized with $375.1 million at the end of 2021, funding planned operations into 2024 CAMBRIDGE,…
Vaxart Provides Business Update and Reports Fourth Quarter and Full Year 2021 Financial Results
Company begins 2022 with multiple active programs with data readouts expected this year Initial data…
Kronos Bio Reports Recent Business Progress and Fourth-Quarter and Full-Year 2021 Financial Results
Phase 1/2 trial of CDK9 inhibitor KB-0742 continues to enroll patients in the dose escalation…
Codexis Reports Fourth Quarter and Fiscal Year 2021 Financial Results
Record Annual Total Revenue of $104.8M, Representing Eighth Consecutive Year of Revenue Growth Company Guides…
Relay Therapeutics Reports Fourth Quarter and Full Year 2021 Financial Results and Corporate Highlights
Announced RLY-4008 interim clinical data that suggest it is the first investigational therapy that selectively…
Vir Biotechnology Provides Corporate Update and Reports Fourth Quarter and Full Year 2021 Financial Results
– Significant progress made increasing global patient access to sotrovimab; approximately 1.7 million doses sold to…
Plus Therapeutics Reports Fourth Quarter and Full Year 2021 Financial Results and Business Highlights
Expanded pipeline with recently licensed targeted interventional radiotherapeutics platform Announced positive interim data from ReSPECT-GBM…
Kura Oncology Reports Fourth Quarter and Full Year 2021 Financial Results
– Patient enrollment continues in KOMET-001 Phase 1b study of ziftomenib (KO-539) in AML –…
Mercury’s first-to-market avionics modules provide safe, powerful, flight-ready computing
Safety-critical multicore 6U solutions accelerate data-intensive sensor processing applications while lowering risk Mercury’s new BuiltSAFE…
INVESTOR ALERT: Law Offices of Howard G. Smith Announces Investigation of C3.ai, Inc. (AI) on Behalf of Investors
BENSALEM, Pa.–(BUSINESS WIRE)–Law Offices of Howard G. Smith announces an investigation on behalf of C3.ai,…
CANbridge Announces Approval of CAN108 for Rare Liver Disease, Alagille Syndrome, Under the Early and Pilot Implementation Policy in Boao Lecheng International Medical Tourism Pilot Zone
BEIJING & CAMBRIDGE, Mass.–(BUSINESS WIRE)–CANbridge Pharmaceuticals, Inc. (“CANbridge”, stock code 1228.HK), a leading China-based global…
KBRA Releases Research – KBRA’s Global Rating Transition Study: 2011-2021
NEW YORK–(BUSINESS WIRE)–#KBRA–KBRA releases a report analyzing the 1-year and lifetime transition of its ratings…
Glancy Prongay & Murray LLP, a Leading Securities Fraud Law Firm, Announces Investigation of Vertiv Holdings Co (VRT) on Behalf of Investors
LOS ANGELES–(BUSINESS WIRE)–Glancy Prongay & Murray LLP (“GPM”), a leading national shareholder rights law firm,…